Ruxolitinib cream 1.5% shows “breakthrough” results as a treatment for prurigo nodularis, according to a presenter at the ...

Chronic prurigo, also known as prurigo nodularis, is a disease characterized by extremely itchy lesions. Due to this persistent itch, patients with this disease tend to experience psychological ...

As Incyte strives to push its topical JAK inhibitor Opzelura into additional dermatology indications, the company’s latest ...

in atopic dermatitis (AD), while late-breaking research highlighted its potential efficacy in prurigo nodularis (PN). This content was developed independently and is not endorsed by the American ...

Incyte INCY announced positive results from two late-stage studies evaluating the safety and efficacy of its twice-daily ...

More than 40% of patients with longstanding prurigo nodularis (PN) had significant improvement within 3 months of starting ...

IL-31 is a protein that drives itch and plays a role in inflammation and skin barrier dysfunction in both AD and prurigo nodularis and fibrosis in prurigo nodularis, the company states.

showing that Nemluvio has the potential to address the significant unmet needs of patients with atopic dermatitis and prurigo nodularis 1-3 There is a need for new treatment options for atopic ...

Galderma (SWX:GALD) today announced that the European Commission has approved Nemluvio for both moderate-to-severe atopic dermatitis and prurigo nodularis in the European Union (EU). Nemluvio is ...